Biosynthetic gene clusters

Streptomyces antarcticus sp. nov., isolated from Horseshoe Island, Antarctica

mycolabadmin

Scientists discovered a new type of bacteria called Streptomyces antarcticus in Antarctic soil that can survive extreme cold and produce valuable compounds. This bacterium can make antibiotics, cancer-fighting molecules, and other useful substances, making it potentially useful for medicine and industry. The bacteria also has genes to break down pharmaceutical pollutants and adapt to harsh conditions, suggesting applications in cleaning up contaminated environments.

Roles of mobile genetic elements and biosynthetic gene clusters in environmental adaptation of acidophilic archaeon Ferroplasma to extreme polluted environments

mycolabadmin

Scientists discovered how a special acid-loving microorganism called Ferroplasma survives and thrives in highly polluted mine drainage environments rich in dangerous heavy metals. The study revealed that these microorganisms use special genetic elements like jumping genes and metabolite-producing genes to adapt to these extreme conditions, enabling them to help clean up pollution. This discovery could lead to better biological methods for treating contaminated environments and making water safer near old mining sites.

Draft genome of Conoideocrella luteorostrata ARSEF 14590 (Clavicipitaceae), an entomopathogenic fungus with a wealth of biosynthetic and biocontrol potential

mycolabadmin

Scientists have sequenced the complete genome of a fungus that naturally kills elongate hemlock scale insects, pests that damage Christmas trees. The fungus contains genes for producing cephalosporin, a well-known antibiotic, and other bioactive compounds. This discovery opens new possibilities for using this fungus as a natural pest control method and potentially developing new medicines from its biological compounds.

Penicillium psychrofluorescens sp. nov., a naturally autofluorescent Antarctic fungus

mycolabadmin

Scientists discovered a new cold-loving fungus in Antarctic soil that glows remarkably bright under ultraviolet light. This fungus, named Penicillium psychrofluorescens, produces its own fluorescent chemicals and contains many genes for making novel medicinal compounds. Its unique characteristics suggest it could be valuable for developing new medicines and biotechnological applications.

Rediscovery of viomellein as an antibacterial compound and identification of its biosynthetic gene cluster in dermatophytes

mycolabadmin

Researchers discovered that skin-infecting fungi called dermatophytes produce a red pigment called viomellein that kills bacteria. By studying the genes responsible for making viomellein, scientists found that this compound may help dermatophytes establish infections by eliminating competing bacteria on the skin. This discovery could explain how these fungi successfully colonize human skin and may lead to new treatment strategies for stubborn fungal infections.

Strategy of employing plug-and-play vectors and LC–MS screening to facilitate the discovery of natural products using Aspergillus oryzae

mycolabadmin

Researchers developed new tools to make it faster and easier to discover useful compounds from fungi. They created improved genetic vectors that allow scientists to insert multiple genes into Aspergillus oryzae more conveniently, and developed a quick screening method using mass spectrometry to identify successful transformants directly on culture plates. This approach saves about 10 days compared to traditional methods, significantly accelerating the discovery of new natural products with potential medical and agricultural applications.

mGem: How many fungal secondary metabolites are produced by filamentous fungi? Conservatively, at least 1.4 million

mycolabadmin

Scientists have discovered about 30,000 fungal compounds with useful properties, from life-saving antibiotics like penicillin to cholesterol-lowering drugs. However, new research suggests that fungi actually produce somewhere between 1.4 million and 4.3 million different chemical compounds, meaning we’ve only discovered about 1-2% of what’s out there. By studying the genomes of fungi, researchers estimate that for every fungal medicine we know about, there could be 50-100 more waiting to be discovered, representing an enormous opportunity for developing new drugs and therapies.

Screening microbial inhibitors of Pseudogymnoascus destructans in Northern China

mycolabadmin

Scientists in Northern China have found bacteria living on bat skin and in cave soil that can kill the fungus responsible for white-nose syndrome, a disease devastating bat populations worldwide. These bacteria produce various antifungal compounds including volatile organic compounds that diffuse through the air and damage the fungus’s structure. By analyzing the genetic makeup of these bacteria, researchers identified specific genes responsible for producing these antifungal compounds, offering hope for developing biological control treatments that could protect bats and reduce fungal loads in cave environments.

Haplotype-Phased Chromosome-Level Genome Assembly of Floccularia luteovirens Provides Insights into Its Taxonomy, Adaptive Evolution, and Biosynthetic Potential

mycolabadmin

Scientists successfully decoded the complete genetic blueprint of the yellow mushroom (Floccularia luteovirens), a valuable medicinal fungus found on the Tibetan Plateau. The high-quality genome assembly revealed the mushroom produces many different beneficial compounds like antitumor and anti-inflammatory molecules. The study also corrected previous scientific confusion about the mushroom’s evolutionary classification, showing it’s more closely related to other fungi than previously thought, and revealed how it adapted to harsh alpine conditions.

Production of the light-activated elsinochrome phytotoxin in the soybean pathogen Coniothyrium glycines hints at virulence factor

mycolabadmin

Researchers discovered that a fungus infecting soybean plants produces red toxins that become dangerous when exposed to light. These toxins generate reactive oxygen species that damage plant cells, causing leaf spots and disease. The study found that disease is worse under light conditions but can still occur in darkness, suggesting multiple attack mechanisms. Understanding this toxin production may help develop better disease management strategies for soybean crops, particularly in Africa where the disease is common.

Research Topic: Biosynthetic gene clusters